title: Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature.
abstract: Neuroendocrine tumors (NET) are rare, but their incidence is gradually increasing. In this study, demographical and tumor characteristics, treatment modalities, responses, and survival rates were evaluated in the patients with NET. Seventy-one patients with NET from 3 tertiary care centers evaluated retrospectively. Overall survival (OS), progression-free survival (PFS), and disease-free survival rates were estimated by Kaplan-Meier Method. Male/female ratio was 0.86 (33/38). Median age was 52 years. Rates for family cancer history and goiter/thyroiditis were 22.4 and 17.8%, respectively. The most common primary site was lung (22.5%), in parallel with the literature, and 31% had the large cell neuroendocrine carcinoma histology. The second most common site was stomach. Carcinoid syndrome rate was found to be 30.6%. Half of the patients were in early stage at diagnosis. Surgical resection rate was 64.7, and 45% of the patient received chemotherapy (CT), 22% received radiotherapy. Seventy-six percent of resected patients had local disease. Thirty-two patients received CT for palliation or concurrent with radiotherapy or in adjuvant setting. Platin/etoposide combination was the most commonly used chemotherapy regimen. Chemotherapy response rate was 35.7%. Five patients had received somatostatin analogue. Radiotherapy was used in adjuvant setting in one-third of the patients. Median OS was 66 months, and median PFS was 30 months. Female gender and fifth decade seem to have higher risk. History for family cancer and goiter/thyroiditis was high in the patients with NET, though there is no data about an association between NET and thyroid disorders in the literature.
authors: Department of Medical Oncology, Ankara University School of Medicine, Cebeci Hospital, 06590 Dikimevi, Ankara, Turkey. mutludogan1@yahoo.com
authors: Mutlu
authors: M
authors: Dogan
authors: Bulent
authors: B
authors: Yalcin
authors: Nuriye Yildirim
authors: NY
authors: Ozdemir
authors: Ulku Yalcintas
authors: UY
authors: Arslan
authors: Lutfi
authors: L
authors: Dogan
authors: Gungor
authors: G
authors: Utkan
authors: Hakan
authors: H
authors: Akbulut
authors: Nurullah
authors: N
authors: Zengin
authors: Necati
authors: N
authors: Alkis
authors: Fikri
authors: F
authors: Icli
references: J Clin Oncol. 2008 Mar 10;26(8):1316-23
references: 18323556
references: J Clin Oncol. 2008 Jun 20;26(18):3063-72
references: 18565894
references: Arch Pathol Lab Med. 2010 Nov;134(11):1628-38
references: 21043816
references: J Clin Oncol. 2006 Aug 1;24(22):3548-54
references: 16877720
references: J Clin Oncol. 1989 Jul;7(7):865-8
references: 2738623
references: Lung Cancer. 2002 Sep;37(3):287-92
references: 12234698
references: J Clin Oncol. 2006 Jan 20;24(3):401-6
references: 16421420
references: J Clin Oncol. 2008 Jul 10;26(20):3403-10
references: 18612155
references: J Exp Clin Cancer Res. 2003 Dec;22(4):517-30
references: 15053292
references: Nature. 1988 Mar 3;332(6159):85-7
references: 2894610
references: Digestion. 2000;62 Suppl 1:92-7
references: 10940694
references: Ann N Y Acad Sci. 2004 Apr;1014:13-27
references: 15153416
references: J Clin Oncol. 2006 Jan 1;24(1):70-6
references: 16382115
references: J Exp Clin Cancer Res. 1997 Dec;16(4):353-63
references: 9505205
references: Appl Radiat Isot. 2009 Feb;67(2):227-33
references: 19027307
references: Cancer. 1991 Jul 15;68(2):227-32
references: 1712661
references: N Engl J Med. 1999 Mar 18;340(11):858-68
references: 10080850
references: Ann N Y Acad Sci. 2004 Apr;1014:199-208
references: 15153435
references: J Clin Endocrinol Metab. 1996 Sep;81(9):3164-7
references: 8784062
references: J Clin Oncol. 1984 Nov;2(11):1255-9
references: 6238136
references: J Clin Oncol. 2008 Sep 10;26(26):4311-8
references: 18779618
references: Ann Surg Oncol. 2009 Feb;16(2):481-6
references: 19030935
references: Hum Mol Genet. 1997 Dec;6(13):2285-90
references: 9361035
references: Ann Oncol. 1999;10 Suppl 2:S9-15
references: 10399027